What does this study add?
• Judicious use of daily broad-spectrum sunscreens with high ultraviolet (UV) A protection will not compromise vitamin D status in healthy people.
• However, photoprotection strategies for patients with photosensitivity disorders that include high sun-protection factor sunscreens with high UVA protection, along with protective clothing and shade-seeking behaviour are likely to compromise vitamin D status.
• Screening for vitamin D status and supplementation are recommended in patients with photosensitivity disorders.
The prevention of rickets and osteoporosis by vitamin D has long been established. More recently, vitamin D has been implicated in many metabolic and immunological disorders as well as many cancers. Its pleiotropic activity may be mediated by modulation of~1000 genes via the vitamin D receptor (VDR), 1, 2 which is expressed by at least 60 human cell types. 3 The VDR controls many cellular functions including growth, differentiation and apoptosis. However, the role of vitamin D in the prevention of nonskeletal diseases remains highly controversial. [4] [5] [6] [7] [8] Terrestrial ultraviolet radiation (UVR) is the main determinant of vitamin D status. Stratospheric ozone absorbs all solar UVC (100-280 nm), attenuates UVB (280-315 nm) but not UVA (315-400 nm). The sun's height determines the UVR pathlength through the ozone layer. Thus, UVB intensity (irradiance) depends mainly on latitude, season and time of day. The ratio of UVA to UVB also varies with the sun's height because of the differential effect of the ozone layer. Thus, terrestrial UVR typically contains ≤ 5% UVB (~295-315 nm) and ≥ 95% UVA.
The minor UVB component is responsible for vitamin D synthesis, 9 the initiating event of which is the isomerization of the epidermal chromophore (a UVR-absorbing molecule) 7-dehydrocholesterol (7-DHC) into pre-vitamin D 3 , which is thermally converted into cholecalciferol (vitamin D 3 ). 10 Pre- contain both hydroxylases for the synthesis of calcitriol. Multiple intrinsic and extrinsic factors modulate vitamin D synthesis and overall status, including genetic polymorphisms, age, geographical location, sun exposure behaviour, UVB dose, clothing, body surface area (BSA) exposed. 13 These are summarized in Figure 1 14 and Appendix S1 (see Supporting Information 15 Solar UVR has many adverse effects, the most obvious of which is sunburn (erythema). The World Health Organization has defined the global solar UV index (UVI) (http://www. who.int/uv/publications/en/UVIGuide.pdf) to allow comparisons of erythemal potential at various geographical locations (latitudes), seasons and times of day. 16 This is a numerical index of the erythemally weighted irradiance of terrestrial UVR. It is divided into five bands: 'low' (1-2), 'moderate' (3-5), 'high' (6-7), 'very high' (8) (9) (10) and 'extreme' (≥ 11). The UVI is primarily an index of UVB irradiance because this spectral region is the main cause of erythema (see Conclusions and recommendations: Spectral considerations: Ultraviolet B, below) and sun protection is advised when the UVI is ≥ 3.
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Global concern about vitamin D deficiency has fuelled debates on the importance of solar exposure to meet vitamin D requirements. [18] [19] [20] [21] The acute and chronic health benefits of using sunscreens are established 22 but there has been concern about their possible impact on vitamin D status. An international panel was tasked to review the published evidence to reach a consensus on the influence of photoprotection by sunscreens on vitamin D status, considering other relevant factors.
Methods
The meets or exceeds the requirement of 97Á5% of the U.S. population, but it is not possible to specify desired individual status. 23 The determination of vitamin D status is discussed in Appendix S2 (see Supporting Information).
Public health perspectives
Hypovitaminosis D is prevalent globally. 22, 24, 25 A systematic review covering 168 000 people from 44 countries reported serum 25(OH)D < 50 nmol L À1 in 37% of studies. 26 This was mainly in the Middle East 27 and Asia Disagreement on recommended doses for vitamin D supplementation arises, in part, from discrepancies of opinion on optimal serum 25(OH)D levels. The doses recommended for supplementation are discussed in Appendix S2 (see Supporting Information), but in case of deficiency, vitamin D supplementation should be 600-800 IU (15-20 lg) daily [but 400 IU (10 lg) in those less than 1-year-old] to achieve at least a target serum level of 50 nmol L À1 .
Sunscreens and sun protection indices
Sunscreens are topical formulations that contain chemicals that attenuate solar UVR. 31, 32 Global regulatory authorities have defined the sun protection factor (SPF) of a sunscreen as a universal quantitative index of protection against erythema, assessed after a single exposure of solar-simulated radiation (SSR; Fig. 3a ). In effect, the SPF is the ratio of SSR dose necessary for a minimal erythema dose (MED) with and without sunscreen application. SPF should be the primary driver of sunscreen choice. These authorities also require UVA protection (see Spectral considerations: Ultraviolet A 31 and a protection factor for visible light. 38 The benefits of sunscreens in photoprotection strategies
The acute and chronic adverse effects of solar UVR, especially to those with fair skins, are well established and can be inhibited by effective sun protection. 22, 25, 39, 40 This includes (i) sun avoidance or seeking shade; (ii) clothing; and (iii) sunscreen use. When used optimally sunscreens can prevent erythema during a week-long holiday, even when the UVI is very high. 41 Laboratory studies have shown than sunscreens can prevent UVR-induced immunosuppression 42 and the formation of DNA damage 43, 44 [specifically cyclobutane pyrimidine dimers (CPD), the action spectrum of which is very similar to erythema]. CPD are thought to be important in many skin cancers. Those with cancer-prone fair skin are especially sensitive to CPD formation, whereas the higher melanin content in dark skin affords much better protection against CPD, especially in the basal layer. [46] [47] [48] [49] [50] A recent study with a high SPF sunscreen and highdose SSR for 5 consecutive days showed significant protection against CPD, even when the sunscreen was applied at 0Á75 mg cm À2 to simulate typical use. 44 A large Norwegian cohort showed that sunscreen use reduced the risk of melanoma. 51 Extensive randomized controlled trials in Australia, with longterm follow-up, have demonstrated the protective properties of a sunscreen against photoageing, melanoma and squamous cell carcinoma, but not basal cell carcinoma.
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Spectral considerations
Ultraviolet B Action spectroscopy shows that UVB is orders of magnitude more effective than UVA for erythema (see 57, 58 ). 45 This means that the SPF is primarily, but not exclusively, a measure of UVB protection. 31 Such protection is essential when UVB doses are high with recreational solar exposure, and in countries with high UVI.
Ultraviolet A There has been an increasing trend over recent years for better UVA protection, with the aim of designing the ideal 'neutral density' sunscreen with 'spectral homeostasis' that mimics shade, i.e. it does not distort the natural solar UVR spectrum. 59 There is no global standard for UVA protection and requirements vary with regulatory domain. 31 The U.S. Food and Drug Administration has recently proposed greater UVA protection. 60 A UVA protection factor (UVA-PF) can be obtained using a sunscreen's ability to inhibit persistent pigment darkening in vivo. 61 Spectral approaches, based on UVB/UVA absorption ratios and bandwidth cover, give qualitative but not quantitative information on UVA protection. 57 and formation of pre-vitamin D 3 . 58 (c) UVR emission spectra weighed for erythema and pre-vitamin D 3 using the emission spectra in Figure 3a and action spectra in Figure 3b . These products give biologically effective energy and are normalized at 315 nm (CIE boundary between UVB and UVA). Comparisons of the UVB source, with and without Kodacel, weighted with the pre-vitamin D action spectrum show the large influence of nonsolar UVR in many laboratory studies. Comparisons of the London solar spectrum weighted with the erythema and pre-vitamin D action spectra show that UVA filters have no influence on vitamin D production.
UVA irradiance is at least 20-fold greater than UVB in sunlight. 62 Furthermore, because UVA is not attenuated by the ozone layer, it is much less prone than UVB to daily, seasonal and geographical variation. Efficient UVA protection is highly recommended in recreational and daily photoprotection strategies, because good UVB protection, which inhibits sunburn, enables prolonged solar exposure and the accumulation of unnaturally high UVA doses. UVA1 (340-400 nm) preferentially induces CPD in the basal layer, which contains stem cells and melanocytes, 63 as well as damaging DNA repair enzymes. 64 Increasing UVA protection for a
given SPF results in a de facto reduction of UVB protection, which might be expected to be beneficial for vitamin D synthesis. Studies in vivo or in 3D skin models, have shown that for a given SPF a high UVA-PF sunscreen offers better protection against pigmentation, photoageing and DNA damage compared with low UVA-PF, and that low SPF sunscreens with high UVA-PF offer such protection (Table 1) . [65] [66] [67] [68] [69] [70] One study, on a reconstructed skin model exposed to daily SSR, showed that a sunscreen with a lower SPF but strong UVA protection was more effective in preventing photodamage compared with a sunscreen with a higher SPF but low UVA protection. 66 Thus, overall there seems to be biological and clinical advantages from increasing UVA protection for a given SPF. Inhibition of gene expression for adverse effects of DUVR DUVR, daylight UVR; FST, Fitzpatrick skin type; GAG, glycosaminoglycans; HLA-DR, human leukocyte antigen -DR isotype; SPF, sun protection factor; SS, sunscreen; SSR, solar simulating radiation, UVA-PF, UVA protection factor; UVR, ultraviolet radiation a SPF/UVA-PF ratios from L'Or eal: ≤ 3, well-balanced UVB-UVA protection (according to EC requirements); > 3, unbalanced SS with low UVA protection. b UVA star (*) rating refers to a sunscreen's UVA : UVB absorbance ratio (Boots star rating method). The higher the rating, the better the 
Holme 2008 0Á375 SED over 24% BSA. 79 A study of Polish children, who did apply sunscreen, on holiday by the Baltic Sea showed that daily borderline erythemal exposure results in a highly significant increase of serum 25(OH)D 3 . 80 These studies suggest that vitamin D synthesis occurs with low UVR doses and therefore sufficient UVR may be transmitted through a sunscreen for vitamin D synthesis.
Sunscreen use and vitamin D status in patients with photosensitivity with strict photoprotection
Patients with genetic and acquired photosensitivity disorders, and those at risk of and/or with a history of skin cancer are advised to practice strict photoprotection, including sunscreen use. This population is an ideal group to assess the effects of rigorous photoprotection. Table 2 shows some of these conditions, [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] in which patients present with low levels of 25(OH)D 3 except in the study of Ulrich et al., 86 in which 25(OH)D 3 was > 132Á5 nmol L À1 in 120 organ transplant recipients. However, it is impossible to attribute low serum 25(OH)D 3 to a given photoprotection strategy because more than one was used. Furthermore, for the most part there were no controls, and supplementation was given or taken in many of the studies. Overall, it is not possible to use these studies for sunscreen guidance for the general population.
Sunscreen use and vitamin D3 synthesis in studies using nonsolar ultraviolet radiation from artificial sources
Laboratory studies offer an obvious way to study the effects of sunscreens under controlled conditions. Five studies have shown that sunscreen application (0Á5-2 mg cm À2 ) inhibited the synthesis of vitamin D (Table 3) . [94] [95] [96] [97] However, the sources used were mainly UVB-rich (Fig. 3a) , including nonsolar UVB (< 295 nm), which is very effective at pre-vitamin D production (Fig. 3b) . Figure 3c shows that such nonsolar wavelengths have a disproportionally large effect, and thus do not reflect environmental reality. Of note, one study showed that 25(OH)D synthesis is dependent on application thickness when 25% of BSA is exposed. 96 It was recently shown that sunscreens block cutaneous vitamin D 3 (cholecalciferol) production with only a minimal effect on circulating 25(OH)D after a single narrowband UVB (~313 nm) exposure. 97 In general, the UVR dose of these studies is low, e.g. this was 0Á8 MED (estimated to be~3 SED in skin type III volunteers) with SPF 50 at 2 mg cm À2 in the study of Libon et al. 97 Taking the SPF at face value means the dose through the sunscreen is 3/50 = 0Á06 SED. However, it should be noted that the labelled SPF value is specific to SSR sources used for SPF testing that meet certain spectral specifications. The 'actual SPF' with nonsolar UVB-rich sources may be considerably higher 98 than labelled SPF in sunlight. This means that the labelled SPFs are in fact meaningless with nonsolar sources. Overall, when taking photobiological considerations into account, the use of sunscreens with non-SSR sources cannot provide reliable data on their effect on vitamin D synthesis for public health purposes. The only way to do such studies reliably would be to use SSR as used in SPF testing, or a fluorescent SSR source. 99 It should be noted that the higher UVB content of SSR than 'typical' terrestrial UVR may also influence results. 100 Furthermore, the SSR doses given should be environmentally realistic and represent a serious challenge to the sunscreen under test.
Sunscreen use for daily and recreational photoprotection and vitamin D status
Questionnaire-based studies Controlled studies Controlled field studies with real sun exposure are the best way to determine the effect of sunscreen use on vitamin D synthesis. Such studies present ethical considerations when considering control groups because lack of sunscreen use could result in sunburn and increased skin cancer risk. Results of such studies are shown in Table 4 A holiday study in Tenerife (Canary Islands) during a week of very high UVI was designed to take the above factors into account, including a discretionary sunscreen-use control group. This showed that intervention with optimal SPF 15 sunscreen use (≥ 2 mg cm À2 ), which inhibited erythema, 41 still enabled very considerable vitamin D production 111 compared with the discretionary sunscreen-use group that had sunburn. A comparison of high vs. low UVA-PF showed greater vitamin D synthesis with the former. Thus, optimal UVA+B protection does not compromise vitamin D increase during recreational exposure. It was estimated that the daily UVR dose through the sunscreen was 0Á4 SED, which is equivalent to 0Á1 MED in a fair-skinned person. 41 Thus, the UVB doses needed for the biosynthesis of vitamin D 3 are indeed very low. Overall, this study shows that it is possible to have the benefits or solar exposure while minimizing the risks.
In conclusion, effective sunscreens must attenuate UVB to prevent erythema. In theory, this should inhibit vitamin D 3 biosynthesis. However, the doses of UVB necessary are low (i.e. substantially suberythemal) so that typical sunscreen use does not lead to vitamin D insufficiency in practice in healthy people. Indeed, even optimal sunscreen use allows good vitamin D synthesis under high UVI conditions. Better UVA protection for a given SPF results in a de facto reduction of UVB protection. UVA protection will have no impact on vitamin D synthesis (see Fig. 3b ), and indeed may prevent photodegradation. Increased UVB for a given SPF should in theory and in practice result in better vitamin D synthesis. Studies done to date have been with lighter-skinned individuals, and conclusions may not apply to those with darker skin types IV-VI who use sunscreens. In such cases, oral supplementation may be advisable.
Summary
Cutaneous vitamin D 3 synthesis is initiated by terrestrial-range UVB and can be achieved with suberythemal exposures to a relatively small BSA. Daily sunscreen use, for nonintentional solar exposure, is mainly based on products with low SPF and high UVA-PF. This is unlikely to impact on vitamin D production. In fact, most studies published to date have shown no association between sunscreen use and vitamin D deficiency, even with regular use of SPF > 15. Some studies have even reported a positive association between sunscreen use and 25(OH)D 3 , suggesting that their use may have increased sun exposure. Indeed, time spent outdoors and BSA exposed to sun have been positively correlated with vitamin D status. Overall, other photoprotection behaviours (such as seeking shade, wearing protective clothing and long sleeves) may have more impact on vitamin D status than sunscreen use. The recommendations of the panel for daily and recreational photoprotection, as well as the need for vitamin D screening and supplementation, are summarized in Table 5 . • Vitamin D status is modulated by many intrinsic and extrinsic factors including genetic polymorphisms, skin type (pigmentation), age, health, sun exposure behaviour, season, latitude, clothing and nutrition.
• Routine 25(OH)D screening is not recommended for healthy children and adults, nor is systemic oral vitamin D supplementation.
However, it should be considered for people with deeply pigmented skins, those wearing clothing that covers most of the body, especially during pregnancy, and the elderly, or persons in institutions.
• Daily photoprotection is recommended for all skin phototypes, subject to local weather conditions and activities. This includes seeking shade, wearing hats and clothing, using sunglasses and broad-spectrum sunscreen use on exposed skin. These strategies will help prevent sunburn, skin cancer and photoageing.
• SPF should also be adapted to lifestyle (clothing, outdoor activity, diet). High UVA-PF is advised in all cases. The panel recommends:
-A daily use of low SPF protection (i.e. SPF 15) with UVA-PF protection in temperate climates with low UVB in wintertime to inhibit photoageing.
-SPF 30 in countries/locations with intense UVB radiation (lower latitudes, high altitudes) irrespective of season.
-High SPF and UVA-PF for recreational activities under intense solar exposure along with clothing and the use of shade.
• Sunscreen use for daily and recreational photoprotection need not compromise skin vitamin D synthesis, even when applied under optimal conditions. Increasing the UVA-PF for a given SPF improves vitamin D 3 production.
• Patients with genetic or acquired photosensitivity disorders require strict photoprotection. Also at risk are patients with a history of skin cancer and organ transplant recipients and those with malabsorption syndromes. Daily SPF 50+ with high UVA protection is strongly recommended for all these patients along with wearing protective clothing and seeking shade. This makes them prone to vitamin D deficiency and supplementation and screening is therefore advised for this population. 
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